Carisma Therapeutics Inc.
(CARM)
undefined
undefined%
At close: undefined
0.39
-2.14%
Pre-market Dec 16, 2024, 05:22 AM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
Revenue | 14.92M | 9.83M | 26.54M | 11.24M | - | - | 425.00K | 29.98M | 990.00K | 2.24M | 1.33M | - | - |
Cost of Revenue | 74.13M | 6.09M | 85.00K | - | 219.00K | 208.00K | - | - | - | - | - | - | - |
Gross Profit | -59.21M | 3.74M | 26.46M | 11.24M | -219.00K | -208.00K | 425.00K | 29.98M | 990.00K | 2.24M | 1.33M | - | - |
Operating Income | -88.73M | -56.16M | -40.79M | -28.38M | -36.87M | -25.70M | -19.98M | 6.17M | -35.20M | -33.78M | -16.63M | -19.49M | -12.68M |
Interest Income | 1.94M | 1.85M | 10.00K | 29.00K | - | - | - | - | - | - | - | - | - |
Pretax Income | -86.88M | -61.23M | -40.78M | -28.35M | -107.50M | -33.69M | -29.03M | 1.90M | -33.45M | -34.16M | -18.02M | -19.66M | -12.83M |
Net Income | -86.88M | -61.23M | -40.77M | -28.32M | -107.50M | -33.69M | -29.03M | 1.89M | -33.45M | -34.53M | -19.43M | -19.82M | -12.98M |
Selling & General & Admin | 29.52M | 3.29M | 6.41M | 5.09M | 12.21M | 11.62M | 7.90M | 11.44M | 9.85M | 8.47M | 4.02M | 4.21M | 3.27M |
Research & Development | 74.13M | 56.62M | 34.39M | 23.29M | 24.44M | 13.87M | 12.22M | 12.20M | 25.97M | 26.70M | 13.79M | 15.26M | 9.41M |
Other Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | 103.65M | 59.91M | 40.79M | 28.38M | 36.65M | 25.49M | 20.13M | 23.64M | 35.82M | 35.17M | 17.81M | 19.48M | 12.68M |
Interest Expense | - | 3.15M | - | - | - | - | - | 247.00K | 1.40M | 376.00K | 1.40M | 168.00K | 151.00K |
Selling & Marketing Expenses | - | 30.41M | - | - | - | - | -170.00K | -3.30M | - | - | - | - | - |
Cost & Expenses | 103.65M | 66.00M | 40.79M | 28.38M | 36.87M | 25.70M | 20.41M | 23.82M | 36.19M | 35.17M | 17.81M | 19.48M | 12.68M |
Income Tax | - | -3.88M | -10.00K | -29.00K | - | 46.86K | - | 5.00K | 1.40M | 376.00K | 1.40M | 168.00K | 151.00K |
Shares Outstanding (Basic) | 33.52M | 106.40K | 9.12M | 5.91M | 4.55M | 3.09M | 1.31M | 1.05M | 949.65K | 732.20K | 426.95K | 355.90K | 426.95K |
Shares Outstanding (Diluted) | 33.52M | 106.40K | 9.12M | 5.91M | 4.55M | 3.09M | 1.31M | 1.09M | 949.65K | 732.20K | 426.95K | 355.90K | 426.95K |
EPS (Basic) | -2.59 | -575.42 | -4.47 | -4.79 | -23.64 | -10.91 | -22.24 | 1.79 | -35.23 | -47.16 | -45.5 | -55.7 | -30.39 |
EPS (Diluted) | -2.59 | -575.42 | -4.47 | -4.79 | -23.64 | -10.91 | -22.24 | 1.74 | -35.23 | -47.16 | -45.5 | -55.7 | -30.39 |
EBITDA | -85.89M | -51.99M | -40.11M | -27.93M | -107.28M | -33.48M | -28.74M | 2.32M | -31.69M | -33.37M | -17.18M | -19.04M | -12.31M |
Depreciation & Amortization | 2.84M | 6.09M | 85.00K | 122.00K | 219.00K | 208.00K | 285.00K | 178.00K | 366.00K | 410.00K | 438.00K | 448.00K | 364.00K |